...
首页> 外文期刊>Medical oncology >Inhibition of JNK1 expression decreases migration and invasion of mouse hepatocellular carcinoma cell line in vitro.
【24h】

Inhibition of JNK1 expression decreases migration and invasion of mouse hepatocellular carcinoma cell line in vitro.

机译:抑制JNK1表达可降低小鼠肝癌细胞株的迁移和侵袭。

获取原文
获取原文并翻译 | 示例
           

摘要

c-Jun N-terminal kinase (JNK) is located in focal adhesion plaque (FAP). JNK is necessary to growth, morphogenesis, and differentiation of cells; especially JNK1 has a close relation with tumors. In this study, we silenced JNK1 by using short hairpin RNA (shRNA) and examined the effect on migration and invasion of mouse hepatocellular carcinoma (HCC) cell line Hca-F in vitro. Three shRNA expression vectors (JNK1shRNA-1, JNK1shRNA-2, and JNK1shRNA-3) were constructed and transfected to Hca-F cells stably. The most effective shRNA was selected by detecting the expression levels of mRNA and protein. Transwell assay was performed to detect the ability of migration and invasion of cells. A negative control sequence (JNK1shRNA control) and non-transfected normal Hca-F cells were treated as control groups. The "Results" showed that the expression vectors of pSilencer-JNK1shRNA were constructed and transfected to Hca-F cells successfully. The most effective shRNA was JNK1shRNA-2. The expressions of mRNA and protein of JNK1 in Hca-F cells after transfection of JNK1shRNA-2 were decreased significantly compared with the other groups (all, P<0.01; all, P<0.05). The ability of migration and invasion was decreased after down-regulation of JNK1 expression (all, P<0.05). These results suggest that the inhibition of JNK1 expression can decrease ability of migration and invasion of mouse hepatocellular carcinoma cell line in vitro. JNK1 plays an important role in lymphatic metastasis of HCC. It may be a new target for gene therapy of lymphatic metastasis of HCC.
机译:c-Jun N末端激酶(JNK)位于粘着斑块(FAP)中。 JNK是细胞生长,形态发生和分化所必需的;特别是JNK1与肿瘤有密切关系。在这项研究中,我们通过使用短发夹RNA(shRNA)使JNK1沉默,并研究了对小鼠肝细胞癌(HCC)细胞Hca-F迁移和侵袭的影响。构建了三个shRNA表达载体(JNK1shRNA-1,JNK1shRNA-2和JNK1shRNA-3),并将其稳定转染到Hca-F细胞中。通过检测mRNA和蛋白质的表达水平来选择最有效的shRNA。进行Transwell测定以检测细胞迁移和侵袭的能力。将阴性对照序列(JNK1shRNA对照)和未转染的正常Hca-F细胞作为对照组。结果表明,构建了pSilencer-JNK1shRNA表达载体,并成功转染到Hca-F细胞中。最有效的shRNA是JNK1shRNA-2。转染JNK1shRNA-2后,Hca-F细胞中JNK1的mRNA和蛋白的表达较其他组明显降低(全部,P <0.01;全部,P <0.05)。 JNK1表达下调后迁移和侵袭能力降低(全部,P <0.05)。这些结果表明,抑制JNK1表达可以降低小鼠肝癌细胞系在体外的迁移和侵袭能力。 JNK1在肝癌的淋巴转移中起重要作用。它可能是肝癌淋巴转移基因治疗的新靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号